A Phase 1 First in Human Study to Assess Safety and Tolerability of AL101
Clinical trial NCT04111666 · COMPLETED
Trial details
- NCT number
- NCT04111666
- Sponsor
- Alector Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-14
- Primary completion
- 2022-06-09
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.